Obesity and insulin resistance, the cardinal features of metabolic syndrome, are closely associated with a state of low-grade inflammation 1, 2 . In adipose tissue chronic overnutrition leads to macrophage infiltration, resulting in local inflammation that potentiates insulin resistance 3, 4 . For instance, transgenic expression of Mcp1 (also known as chemokine ligand 2, Ccl2) in adipose tissue increases macrophage infiltration, inflammation and insulin resistance 5, 6 . Conversely, disruption of Mcp1 or its receptor Ccr2 impairs migration of macrophages into adipose tissue, thereby lowering adipose tissue inflammation and improving insulin sensitivity 5, 7 . These findings together suggest a correlation between macrophage content in adipose tissue and insulin resistance. However, resident macrophages in tissues display tremendous heterogeneity in their activities and functions, primarily reflecting their local metabolic and immune microenvironment 8 . While Mcp1 directs recruitment of pro-inflammatory classically activated macrophages to sites of tissue damage 5, 8 , resident macrophages, such as those present in the adipose tissue of lean mice, display the alternatively activated phenotype 9 . Despite their higher capacity to repair tissue 10 , the precise role of alternatively activated macrophages in obesityinduced insulin resistance remains unknown. Using mice with macrophage-specific deletion of the peroxisome proliferator activated receptor-c (PPARc), we show here that PPARc is required for maturation of alternatively activated macrophages. Disruption of PPARc in myeloid cells impairs alternative macrophage activation, and predisposes these animals to development of diet-induced obesity, insulin resistance, and glucose intolerance. Furthermore, gene expression profiling revealed that downregulation of oxidative phosphorylation gene expression in skeletal muscle and liver leads to decreased insulin sensitivity in these tissues. Together, our findings suggest that resident alternatively activated macrophages have a beneficial role in regulating nutrient homeostasis and suggest that macrophage polarization towards the alternative state might be a useful strategy for treating type 2 diabetes.
To distinguish between the pathogenic and reparative functions of macrophages in metabolic disease, we sought to identify transcriptional regulators that control alternative macrophage activation. Notably, PPARc, a genetic sensor of fatty acids 11 , is markedly induced in macrophages stimulated with interleukin-4 (IL-4) 12, 13 , prompting us to examine its role in alternative macrophage activation. Because Balb/c mice-but not C57Bl/6 mice-can fully support maturation of alternatively activated macrophages 14 , we generated macrophagespecific PPARc knockout (Mac-PPARc KO) mice on the T helper 2 (Th2)-permissive Balb/c strain (see Methods). Quantitative polymerase chain reaction (Q-PCR) analysis of genomic DNA from peritoneal elicited cells and bone-marrow-derived macrophages showed high excision efficiency (,85-90%) in Mac-PPARc KO animals ( Supplementary Fig. 1a ). Immunoblot analysis further confirmed the absence of PPARc protein in bone-marrow-derived macrophages from Mac-PPARc KO mice ( Supplementary Fig. 1b) . Verifying a critical role for PPARc in alternative activation, arginase I messenger RNA and activity-both hallmarks of alternatively activated macrophages 10 -were reduced by 40% and 50%, respectively, in IL-4 stimulated PPARc null bone-marrow-derived macrophages ( Supplementary Fig. 1c and Fig. 1a) .
To determine whether the arginase I gene is a direct transcriptional target of PPAR/RXR heterodimers, we analysed its promoter region for PPAR response elements. A putative PPAR response element was identified in the distal enhancer of the arginase I gene, a region known to be essential for its expression in alternatively activated macrophages 15 . Electromobility gel shift assays confirmed that PPAR/RXR heterodimers bound to the identified site in a sequencespecific manner ( Supplementary Fig. 1d ). To verify that PPARc/RXR heterodimers can activate the arginase I promoter in vivo, cells of the mouse macrophage cell line RAW264.7 were transiently transfected with luciferase reporter construct driven by ,4 kilobases (kb) of mouse arginase I promoter/enhancer. Treatment of transfected macrophages with IL-4 led to a ,9-fold increase in luciferase activity (Fig. 1b) . Moreover, the addition of PPARc and its ligand, rosiglitazone, enhanced the ability of IL-4 to activate the arginase I promoter (twice the IL-4 stimulated level), demonstrating that PPARc directly regulates this important facet of macrophage activation. Because alternatively activated macrophages can counteract excessive secretion of pro-inflammatory cytokines 13 , we examined whether IL-4 could appropriately attenuate lipopolysaccharide-induced TNFa and IL-6 secretion. Although lipopolysaccharide-stimulated release of TNFa and IL-6 was not significantly different between the two genotypes ( Fig. 1c and Supplementary Fig. 1e ), IL-4 failed to suppress the secretion of IL-6 in macrophages deficient in PPARc (Fig. 1c) , which indicates that a subset of IL-4 dependent anti-inflammatory responses are regulated by PPARc.
We recently reported that a switch to oxidative metabolism is an integral component of alternative macrophage activation 13 . Because PPARs regulate fatty acid homeostasis in many cell types 16 , we investigated the requirement for PPARc or PPARd (the two major PPAR subtypes expressed in murine macrophages) in controlling this oxidative switch. Surprisingly, PPARc, rather than PPARd, was required for IL-4 induced increase in b-oxidation of fatty acids, as shown by the ,70% reduction in the rate of fatty acid oxidation in IL-4-stimulated PPARc null macrophages (Fig. 1d) . In agreement with this genetic data, ligand activation of PPARc led to a doubling of the rate of b-oxidation ( Supplementary Fig. 1f ). Moreover, Q-PCR analyses with reverse transcription revealed that expression of genes controlling lipolysis (Lpl), fatty acid uptake (CD36), and oxidation (Acadm, Acadl) was reduced in IL-4-stimulated PPARc null macrophages ( Supplementary  Fig. 1g ). In contrast, fatty acid uptake rates were similar in control and Mac-PPARc KO macrophages (Supplementary Fig. 1h ).
An increase in cellular mitochondrial content accompanies this metabolic switch, so we tested the requirement for PPARc in mitochondrial biogenesis. Cellular staining with MitoTracker Green revealed an absolute requirement for PPARc in mediating the biogenic effects of IL-4 (Fig. 1e ). Fluorescence microscopy with MitoTracker Red further verified that reduction in respiring mitochondria largely accounted for the observed decrease in total mitochondria in these cells (Supplementary Fig. 1i ). Consistent with these findings, IL-4 failed to induce the mitochondrial proteins cytochrome C and voltagedependent anion chanel 1 (VDAC1) in PPARc-deficient macrophages (Fig. 1f) . Lastly, the observed impairment in alternative activation was independent of the upstream IL-4 signalling pathway, because PPARcdeficient macrophages expressed similar levels of IL-4Ra protein on their cell surface and stimulation with IL-4 resulted in equivalent levels of phosphorylation of the transcription factor STAT6 ( Supplementary  Fig. 2a, b) .
To provide an independent test for whether PPARc can regulate the macrophage program of alternative activation in vivo, we used an immunological model for studying macrophage Th2-type responses. Cutaneous infection with Leishmania major in Th2-biased Balb/c mice leads to non-healing lesions, whereas the Th1-prone C57Bl/6 mice are resistant to acute infection 17 . Importantly, because impairment in alternative macrophage activation can delay disease progression in Balb/c mice 18 , we investigated whether Mac-PPARc KO mice were also resistant to cutaneous leishmaniasis. Indeed, Mac-PPARc KO mice had significantly less footpad swelling 5-7 weeks after injection of L. major promastigotes (Fig. 2a) . Lesions in Mac-PPARc KO started to stabilize after 7 weeks, but the footpads of control mice continued to enlarge and rapidly underwent necrosis (Fig. 2b) . Consistent with local extension of disease, the draining popliteal lymph nodes were hypercellular and enlarged in control mice (Supplementary Fig. 3 ). Because these results mimic the phenotype of mice lacking alternatively activated macrophages, our data strongly suggest that PPARc is required for acquisition and maintenance of the alternatively activated phenotype.
On the basis of these results, we tested whether genetic deletion of PPARc in macrophages would exacerbate the development of metabolic syndrome. Cohorts of control and Mac-PPARc KO mice were challenged with a high fat diet for 18 weeks to promote maximal infiltration of macrophages into adipose tissue 4 . Surprisingly, MacPPARc KO mice gained more weight than control mice on the high fat diet. After 17 weeks on a high fat diet, the body weight of MacPPARc KO mice (46.7 6 2.3 g) exceeded that of control mice (40.3 6 1.2 g) by ,15% (Fig. 3a) . Dual-energy X-ray absorptiometry showed a 20% increase in total fat mass and a 12% increase in adiposity in Mac-PPARc KO animals ( Fig. 3b) . Consistent with an increase in adiposity, epididymal fat pads were larger (,18% by mass) and serum leptin levels were higher (,57%) in Mac-PPARc KO mice ( Supplementary Fig. 4a , b) 19 . However, adipocyte cell size was not significantly different ( Supplementary Fig. 4c, d ).
To define the alterations in adipose tissue better, we quantified the transcript levels of genes important in adipocyte differentiation and fatty acid metabolism. As shown in Fig. 3c , mRNA levels of a large number of genes involved in nutrient uptake, fatty acid synthesis, and b-oxidation were reduced by ,50-80% in the white adipose tissue of Mac-PPARc KO mice, indicating a global suppression of adipocyte function. Direct co-culture of PPARc-deficient macrophages with adipocytes led to a marked reduction of insulin-stimulated glucose LETTERS uptake in adipocytes (Fig. 3d) , suggesting a causal relationship between PPARc-deficient adipose tissue macrophages (ATMs) and dysregulation of adipocyte metabolism. Remarkably, this was confirmed by Q-PCR analysis of co-cultured adipocytes, which showed suppression of adipocyte gene expression by PPARc-deficient macrophages ( Supplementary Fig. 4e ).
To determine whether macrophage infiltration or aberrant activation contributed to adiposity, we analysed macrophage-specific gene expression in the white adipose tissue of control and Mac-PPARc KO mice. Despite being more obese, transcript levels of macrophagespecific markers, Emr1 and CD68, were reduced by ,70% in the white adipose tissue of Mac-PPARc KO mice (Fig. 3e) . Consistent with the Q-PCR data, histological analysis showed marked reduction in the macrophage content of the white adipose tissue of Mac-PPARc KO mice (Fig. 3f, g ). Importantly, expression of genes preferentially expressed in alternatively activated macrophages 10 , such as ArgI, Mrc1, and Clec7a, was also decreased by ,70-80% in the white adipose tissue of Mac-PPARc KO mice (Fig. 3e) , suggesting that macrophage-specific deletion of PPARc leads to specific reduction in alternatively activated macrophages. The absence of alternatively activated ATMs increased local inflammation in white adipose tissue, as shown by higher expression of IL-6 and Nos2 (Fig. 3e) . Lastly, although ATM content is much lower in lean mice 3, 9 , Q-PCR analysis of white adipose tissue revealed that chow-fed (a low-fat diet) MacPPARc KO mice expressed much lower levels of genes associated with the alternative state ( Supplementary Fig. S5a ).
While the Th2 cytokines IL-4 and IL-13 are required for maturation of alternatively activated macrophages during parasitic infections 10, 14 , the importance of this signalling pathway in ATM biology has not been formally tested. To determine whether IL-4/ IL-13 signalling is required for acquisition of the alternative phenotype by ATMs, we analysed the molecular signature of ATMs in mice defective in IL-4/IL-13 signalling, in particular, the STAT6 null and Mac-IL-4Ra KO mice 14, 20 . Consistent with a critical role for Th2 cytokines in alternative activation, the molecular signature of alternatively activated ATMs was dramatically reduced in lean STAT6 null and Mac-IL-4Ra KO mice ( Supplementary Fig. 5b, c) . Moreover, the expression profile of ATMs in obese STAT6 null mice was identical to the profile observed in obese Mac-PPARc KO mice (compare Fig. 3e and Supplementary Fig. 5d ). The molecular signatures of ATMs in three distinct genetic models (Mac-PPARc KO, STAT6 null and Mac-IL-4Ra KO) were similar, so our data show that an intact IL-4/IL-13/STAT6/PPARc axis is required for maturation of alternatively activated ATMs. Furthermore, to investigate whether stimulation of ATMs by IL-4 is sufficient to polarize them towards the alternative state, obese control and Mac-PPARc KO mice were injected with recombinant IL-4, and ATM gene expression was monitored by Q-PCR. Supplementary Fig. 5e shows that IL-4 induced the expression of alternatively activated markers (Arg1, Chi3l3, Mrc1 and Jag1) in a PPARc-dependent manner.
To explore the role of alternatively activated macrophages in obesityinduced insulin resistance, we performed glucose and insulin tolerance tests in control and Mac-PPARc KO mice. Oral glucose tolerance tests revealed that Mac-PPARc KO mice were significantly more glucose intolerant after an 18-week high fat diet challenge (Fig. 4a) . As would be expected with a decrease in insulin sensitivity, Mac-PPARc KO mice were more resistant to the glucose lowering effects of exogenous insulin (Fig. 4b) . Moreover, after a 4-h fast, paired blood glucose and serum insulin levels were much higher in Mac-PPARc KO mice, with blood glucose levels at 170 6 9.2 mg dl 21 versus 125 6 2.3 mg dl
21
(P , 0.0007) and serum insulin levels at (3.00 6 0.77 ng ml 21 versus 0.24 6 0.02 ng ml 21 (P , 0.002), (Fig. 4c) . The calculated homeostasis model assessment (HOMA) measure of insulin resistance was significantly higher in Mac-PPARc KO mice (Fig. 4d) . To investigate the potential sites of insulin resistance, control and Mac-PPARc KO mice were injected with saline or insulin (5 mU g 21 ) through their inferior vena cava, and liver and skeletal muscle were quickly harvested for biochemical analysis. Strikingly, insulin-stimulated phosphorylation of AKT was markedly decreased in liver and skeletal muscle of MacPPARc KO mice (Fig. 4e, f) , findings consistent with the presence of insulin resistance in these tissues.
Mitochondrial dysfunction in muscle is associated with the onset of insulin resistance and type 2 diabetes [21] [22] [23] [24] , prompting us to examine mitochondrial gene expression in the skeletal muscles of obese mice. Q-PCR analyses showed that mRNAs encoding key enzymes in fatty acid oxidation (Cpt1b, Acox1) and oxidative phosphorylation (Ndufs1, Sdh, Atp5j and Atp5b) were reduced by 30-70% in the quadriceps muscles of Mac-PPARc KO mice (Fig. 4g) . Moreover, expression level of transcription factors and coactivator proteins controlling mitochondrial biogenesis 25, 26 , including Tfam, ). c, Fasting serum insulin levels in control and Mac-PPARc KO mice after a 4 h fast. d, The HOMA insulin resistance index of insulin sensitivity: insulin (ng ml
) 3 glucose (mM). e, f, Decreased insulin signalling in obese Mac-PPARc KO mice. Cellular lysates were immunoblotted for the total amount of the oncoprotein Akt and for serine phosphorylated (S473) Akt in liver (e) and quadriceps (f). g, h, Relative transcript levels of various genes involved in b-oxidation and oxidative phosphorylation, and of transcriptional regulators controlling these pathways in quadriceps (g) and liver (h). i, Circulating levels of adiponectin in control and Mac-PPARc KO mice. Data presented as mean 6 s.e.m. *P , 0.05; **P , 0.01. (Fig. 4g) . Similarly, expression of genes in the electron transport chain and their transcriptional regulators was reduced by 30-60% in the livers of Mac-PPARc KO mice (Fig. 4h) . Nonetheless, these livers did not display any overt signs of steatosis ( Supplementary Fig. 6c, d ), potentially reflecting their intact capacity to undergo b-oxidation (Supplementary Fig. 6e ).
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These findings suggest that direct or indirect effects of alternatively activated macrophages are important in maintaining oxidative capacity in skeletal muscle and liver. Because we did not observe significant differences in macrophage content or activation in liver and skeletal muscle of control and Mac-PPARc KO mice (Supplementary Fig. 6a, b and data not shown) , we focused on factors secreted by adipocytes that modulate oxidative metabolism in peripheral tissues 19, 27 . Notably, recent studies have shown that adiponectin, a hormone specifically secreted by adipocytes, can induce PGC-1a and mitochondrial biogenesis in skeletal muscle 28 . Consistent with the global reduction in adipocyte function (Fig. 3c) and skeletal muscle oxidative capacity (Fig. 4g) , the circulating level of adiponectin was reduced by ,18% in Mac-PPARc KO mice (Fig. 4i) . In contrast, serum levels of resistin, total cholesterol and triglycerides were similar in both strains of mice (Supplementary Table 1 ).
In summary, the requirement for PPARc in expression of the alternatively activated phenotype, the absence of alternatively activated ATMs in Mac-PPARc KO mice, and the observation that MacPPARc KO mice are more susceptible to obesity and insulin resistance suggest that this program of macrophage activation protects against the metabolic consequences of obesity. In this setting of excess caloric intake, homeostatic functions performed by alternatively activated ATMs might allow animals to store and oxidize incoming lipids more efficiently, thereby maintaining insulin sensitivity and glucose tolerance. However, our findings raise additional issues that will require further investigation. First, to validate whether alternatively activated macrophages can be therapeutically exploited to treat type 2 diabetes, genetic and pharmacologic approaches that activate or inhibit IL-4 signalling in macrophages need to be tested. Second, although the presence of alternatively activated ATMs attenuates inflammation, we cannot exclude the possibility that remodelling activities of these cells might also lead to improvement in adipose tissue function. Lastly, in addition to their paracrine effects, it is plausible that peptides or lipids secreted by alternatively activated ATMs act in an endocrine fashion to modulate peripheral insulin sensitivity. ;LysM Cre animals. Mice were genotyped for the presence of floxed and deleted alleles as described previously 29 , and littermates were used to assemble the cohorts used in these studies.
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METHODS
Functional analysis for alternative macrophage activation. Bone-marrowderived macrophages from control, Mac-PPARc KO and PPARd 2/2 (on the 129Sv background) mice were cultured as described in previously 13 . To promote alternative macrophage activation, bone-marrow-derived macrophages were stimulated with IL-4 (10 ng ml 21 ) for 24-96 h. Arginase I activity was monitored via a colorimetric assay that detects the production of urea 15 . Fatty acid oxidation rates in macrophages were quantified using the sodium hydroxide trap in a modified tissue culture flask 13 . Cellular mitochondrial content was quantified using MitoTracker dyes (Molecular Probes), according to the manufacturer's instructions. All assays were performed in duplicate or triplicate and repeated at least three independent times, and total cell number or protein content was used for normalization of the data. Gel mobility shift assays and transient transfections. In vitro translated proteins (TNT kit, Promega) and 32 P end-labelled oligonucleotides were used to carry out the gel mobility shift assays. Competition assays were performed with excess unlabelled oligonucleotides. The acyl-CoA oxidase PPAR response element served as a positive control for these studies. The sequence of the arginase I PPAR response element is (two half sites separated by a base pair): AAGTCA G AGAGCA. Transient transfection experiments were performed in RAW 264.7 cells. Briefly, cells were electroporated via the GenePulser II (BioRad) at 300 V, 1,000 mF, and allowed to recover overnight. Luciferase assays were performed 16-20 h after stimulation with IL-4 (10 ng ml
21
) or rosiglitazone (1 mM) with the Dual-Luciferase reporter assay system (Promega). The phRLnull plasmid (Promega) was used as an internal control to monitor transfection efficiency. All transfections were done in triplicate and repeated at least three times. Immunoblots, ELISAs and immunohistochemistry. Total cellular proteins were immunoblotted for cytochrome C (1:1,000, BD Pharmingen), VDAC1 (1:2000, Molecular Probes), and b-actin (1:5,000, Sigma). Infrared dye (IR Dye 800) conjugated secondary antibodies (1:30,000, Rockland) were used for protein detection. For ELISAs, macrophages pre-treated with IL-4 (10 ng ml 21 ) for 24 h were subsequently stimulated with lipopolysaccharide (5 ng ml 21 ) for 6 h (TNFa) or 24 h (IL-6). Cytokine secretion was quantified by ELISA, according to the manufacturer's protocols (BD Pharmingen). All assays were done in triplicate and repeated at least three independent times. Macrophages in the gonadal fat pads were visualized by F4/80 immunostaining and quantified as described previously 7 . Gene expression analysis. Trizol reagent (Invitrogen) was used to prepare total RNA from macrophages or tissues. Total RNA (2 mg) was treated with DNase (1 U ml
) and reverse transcribed using a first-strand complementary DNA synthesis kit (Marligen). Q-PCR assays were carried out in triplicate on the DNA Engine Opticon 2 real-time PCR detection system. Relative expression levels for mRNAs were calculated using the comparative C T method normalized to the L32 RNA. Leishmania infection. Leishmania major (strain WHOM/IR/-/173) promastigotes were cultured at 27 uC in M199 containing 15% fetal bovine serum, 100 U ml 21 penicillin, 2 mM glutamine, 100 mM adenine, 5 mg ml 21 haemin, and 40 mM HEPES. Stationary phase metacyclic promastigotes (2 3 10 6 ) were injected into the left hind footpad 18 . Footpad thickness was measured weekly using a caliper (Mitutoyo), and reported as the difference in thickness between the infected and uninfected footpads. Footpad necrosis was graded using the following scale: 0, no visible abscesses; 1, one or more visible subcutaneous abscesses; 2, point surface necrosis; 3, surface necrosis over ,50% of foot pad; 4, surface necrosis over .50% of foot pad; and 5, death of the foot. Metabolic studies. Mice were fed a high fat diet (Bio-Serv F3282) to promote obesity. Oral glucose tolerance tests (1 g kg
) were performed after an overnight fast. For the insulin tolerance test, mice were fasted for 4 h before injection of human regular insulin (0.65 U kg 21 ). Tail blood glucose levels were monitored at 0, 15, 30, 60 and 120 min time points with the Bayer Elite glucometer. For biochemical analysis of insulin signalling, obese mice of both genotypes were injected with insulin (5 mU g 21 ) through their inferior vena cavas after a 4 h fast. Liver and quadriceps were isolated 2 and 5 min, respectively, after insulin injection. Homogenized proteins were immunoblotted for total Akt and phosphoAkt (S473, Cell Signaling). Serum levels of adipokines (leptin, adiponectin and resistin), cytokines (TNFa, IL-6 and IL-1b), lipids (total cholesterol and triglycerides), and insulin in fasted mice was quantified using commercially available kits. Macrophage/adipocyte co-culture. Macrophage/adipocyte direct co-culture experiments were performed as described previously 30 . Briefly, 100,000 bonemarrow-derived macrophages (day 10) were co-incubated with differentiated 3T3-L1 adipocytes (day 8) for 48 h. Cultures were stimulated with insulin (100 nM) for 30 min, and glucose uptake was monitored using 0.2 mM 2-[ ) over 5 min. Incorporated radioactivity was normalized for protein content, and expressed as fold increase over untreated samples. Statistical analysis. Data are presented as mean 6 s.e.m., and Student's t-test (two-tailed distribution, two-sample unequal variance) was used to calculate the P value. Statistical significance is displayed as P , 0.05 (one asterisk) or P , 0.01 (two asterisks).
